Clinical outcomes in pediatric acute lymphoblastic leukemia using modified BFM-95 protocol: 10-year study in Mexico city.
Open Access
- 13 June 2026
- journal article
- Published by Oxford University Press (OUP) in JNCI Cancer Spectrum
- Vol. 10 (4)
Abstract
Although survival rates for acute lymphoblastic leukemia (ALL) in developed countries have reached up to 80%, outcomes remain considerably lower in emerging nations. This study aimed to evaluate the 10-year survival of pediatric patients with ALL treated at a public hospital using the HP 09 protocol, adapted from the BFM 95 protocol. We included patients under 17 years of age diagnosed with ALL and treated with the HP 09 protocol between January 2010 and December 2020. Patients were stratified into three risk groups according to clinicobiological characteristics. A total of 253 patients were analyzed. The cohort demonstrated a 10-year overall survival (OS) rate of 58.1% (90.4 ± 4.8 months) and an event-free survival (EFS) rate of 56.9% (78.2 ± 5.0 months). By risk group, the 10-year OS was 41% in the high-risk group, 61.9% in the intermediate-risk group, and 85.7% in the standard-risk group. Corresponding 10-year EFS rates were 55.2%, 57.1%, and 59.7%. Cox regression analysis identified older age (>10 years; OR 2.11, CI 1.36 to 3, P=.001), leukocyte count >50 × 109/L (OR 1.89, CI 1.22 to 2.93, P=.004), and prior steroid exposure before diagnosis (OR 2.30, CI 1.16 to 4.58, P=.017) as significant predictors of relapse. This study highlights a substantial disparity in survival rates among pediatric patients with ALL in Mexico compared with international benchmarks. The gap likely reflects differences in chemotherapy efficacy, disease biology, and systemic healthcare limitations.Keywords
This publication has 26 references indexed in Scilit:
- Clinical Outcomes of Pediatric Acute Lymphoblastic Leukemia in the Bajio Region of Mexico: A Retrospective Cohort StudyIndian Journal of Hematology and Blood Transfusion, 2024
- Central nervous system involvement in childhood acute lymphoblastic leukemia: challenges and solutionsLeukemia, 2022
- Results of two consecutive treatment protocols in Polish children with acute lymphoblastic leukemiaScientific Reports, 2020
- Extremely Low‐Frequency Magnetic Fields and the Risk of Childhood B‐Lineage Acute Lymphoblastic Leukemia in a City With High Incidence of Leukemia and Elevated Exposure to ELF Magnetic FieldsBioelectromagnetics, 2020
- Results of Treating Childhood Acute Lymphoblastic Leukemia in a Low-middle Income Country: 10 Year Experience in Northeast MexicoArchives of Medical Research, 2016
- The treatment of childhood acute lymphoblastic leukemia in Guatemala: Biologic features, treatment hurdles, and resultsCancer, 2016
- Treatment of Childhood Acute Lymphoblastic Leukemia: Prognostic Factors and Clinical AdvancesCurrent Hematologic Malignancy Reports, 2016
- Childhood acute lymphoblastic leukemia in Nicaragua: Long‐term results in the context of an international cooperative programPediatric Blood & Cancer, 2013
- Acute lymphoblastic leukaemiaThe Lancet, 2013
- Treatment of children with acute lymphoblastic leukemia in India using a BFM protocolPediatric Blood & Cancer, 2008